In recent years the option to purchase medications from India has gained significant popularity offering a reliable and affordable solution for people worldwide India has emerged as a trusted source f ...

Lenacapavir is a long-acting injectable drug that has proven 100 per cent successful in clinical tests and subsequent human ...

With Gilead sprinting to a likely approval next year for its long-acting pre-exposure | With GSK girding for competition from ...

From an anal PrEP douche to the first women-controlled HIV prevention product, here's all the new HIV prevention products ...

Historically, as mentioned, PrEP has been used to treat cisgender gay men, especially in light of the HIV crisis of the 1980s ...

Three absurdly cheap dividend stocks that are trading at modest multiples of their expected earnings today are Merck ( MRK -0 ...

GILD and partner MRK advance novel investigational combination regimen, a weekly oral HIV treatment, to phase III.

Gilead Sciences, Inc. GILD recently announced additional efficacy, safety and demographic data from its late-stage study on lenacapavir, a twice-yearly injectable HIV-1 capsid inhibitor, for the ...

CAB LA is an injectable medication used for HIV pre-exposure prophylaxis (PrEP ... The U.S. FDA first approved CAB LA for PrEP in 2021 under the brand name “Apretude.” Since then, ViiV ...

The drug, known by its brand name Truvada, is developed by U.S. drugmaker Gilead Sciences. It was first approved for use as a pre-exposure prophylaxis (PrEP) — medication to prevent HIV ...

HIV/AIDS: Key interventions and progress so ... Gilead Sciences had first launched Lenacapavir under the brand name Sunlenca in the U.S. and Europe markets in 2022. Dr. Reddy’s said as part ...

Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) is a brand-name tablet prescribed for HIV-1. As with other drugs, Biktarvy can cause side effects, such as ...